Joanne Gibbons

General Counsel bei MORPHIC HOLDING, INC.

Health Technology

Consumer Services

Profil

Joanne Gibbons is currently working as the Senior Vice President-Regulatory Affairs at Morphic Holding, Inc. She previously worked as the Senior Director-Regulatory Affairs at Wave Life Sciences Ltd.
and as the Vice President & Head-Regulatory Affairs at Codiak BioSciences, Inc. Prior to that, she held the position of Head-Global Regulatory Strategy at Biogen, Inc. from 1999 to 2017.
Ms. Gibbons completed her undergraduate degree at Tufts University.

Aktive Positionen von Joanne Gibbons

Unternehmen	Position	Beginn
MORPHIC HOLDING, INC.	General Counsel	18.05.2022

Alle aktiven Positionen von Joanne Gibbons

Ehemalige bekannte Positionen von Joanne Gibbons

Unternehmen	Position	Ende
BIOGEN INC.	Corporate Officer/Principal	01.08.2017
WAVE LIFE SCIENCES LTD.	Corporate Officer/Principal	-
CODIAK BIOSCIENCES	General Counsel	-

Sehen Sie sich die Erfahrung von Joanne Gibbons im Detail an

Ausbildung von Joanne Gibbons

Tufts University

Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Joanne Gibbons im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	3
BIOGEN INC.	Health Technology
WAVE LIFE SCIENCES LTD.	Health Technology
MORPHIC HOLDING, INC.	Health Technology

Private Unternehmen	1
Codiak BioSciences, Inc. Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Codiak BioSciences, Inc. engages in the development and manufacturing of exosomes. It engages in harnessing exosomes, therapeutic applications, diagnostic applications, and proprietary production. The firm develops engEx Platform, a proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. Codiak BioSciences was founded by Douglas E. William, Raghu Kalluri, and Eric S. Lander in 2015 and is headquartered in Cambridge, MA.	Health Technology